Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Tianjin Tianyao Pharmaceutical Co's average Total Assets Growth Rate was -4.00% per year.
During the past 3 years, the average Total Assets Growth Rate was -6.30% per year.
During the past 5 years, the average Total Assets Growth Rate was -4.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 5.90% per year.
During the past 13 years, Tianjin Tianyao Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 35.10%. The lowest was -6.30%. And the median was 10.80%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Tianjin Tianyao Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Tianjin Tianyao Pharmaceutical Co Total Assets Related Terms
Tianjin Tianyao Pharmaceutical Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Tianyao Pharmaceutical Co Total Assets Chart
Tianjin Tianyao Pharmaceutical Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) has a Total Assets of ¥5,635 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors.
Is Tianjin Tianyao Pharmaceutical Co's Total Assets too high?
Tianjin Tianyao Pharmaceutical Co's current Total Assets is ¥5,635 Mil. Overall, Tianjin Tianyao Pharmaceutical Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Tianyao Pharmaceutical Co's Total Assets compare to ZTS and UTHR?
Tianjin Tianyao Pharmaceutical Co's Total Assets of ¥5,635 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. Tianjin Tianyao Pharmaceutical Co's current Total Assets is ¥5,635 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Tianyao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co (SHSE:600488) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.59, compared to a current price of ¥6.89 — trading 91.9% above its estimated fair value. The current Total Assets is ¥5,635 Mil. Tianjin Tianyao Pharmaceutical Co's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Tianjin Tianyao Pharmaceutical Co (SHSE:600488), the current Total Assets is ¥5,635 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥6.89 is trading 91.9% above its estimated GF Value™ of ¥3.59.
GuruFocus considers Tianjin Tianyao Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:600488:
Total Assets: ¥5,635 Mil
GF Value™: ¥3.59 vs. price of ¥6.89 (91.9% above fair value)
No single metric tells the full story. See the SHSE:600488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin Tianyao Pharmaceutical Co Business Description
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
56GF Score
Get the complete analysis for SHSE:600488
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600488 has been successfully added to your 
